Influence
September 1, 2025

Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research

Johanne Eliacin and Sophia Wang

Published in the Alzheimer’s and Dementia. Here is a link to the article.

Regenstrief Institute authors: Regenstrief Research Scientist Johanne Eliacin, PhD, and Regenstrief Affiliate Scientist Sophia Wang, M.D.

The study found that trust in researchers is the strongest factor influencing whether older adults are willing to participate in Alzheimer’s disease and related dementia (ADRD) biomarker research. In a survey of 399 older adults with no previous research involvement, those who expressed very high trust were significantly less hesitant to take part in studies, even after accounting for differences in age, education, race and knowledge of ADRD.

Participants with higher trust were more willing to undergo procedures such as brain scans, blood draws and genetic testing, and they showed greater interest in receiving personal results from memory and brain imaging tests. Those with lower trust were more likely to have concerns about privacy and the risks of research procedures.

The study also revealed that simply knowing more about ADRD did not increase willingness to participate, underscoring trust as an independent and essential factor. Offering personal health results was more effective at encouraging participation among those who already had higher trust, while incentives like travel vouchers or standard lab results had little impact.

These findings highlight the critical role of building trust between researchers and communities to increase participation in studies that are essential for advancing early detection and treatment of ADRD. Strengthening trust through transparent communication and strong community partnerships may help accelerate progress in developing effective therapies.

Authors:

Laureen Raelly-Muze1,2 Taylor Etchison2 Adele Crouch3 Johanne Eliacin2,4,5,6,7

Angelina Polsinelli2,8 Sujuan Gao2,9 Sarah Van Heiden2 Joseph Asper2

Caprice Elliott2 Ralph Richards2 Mollie Richards2 Christopher Campbell2

Hugh Hendrie2 Pamella Shaw2 Omolola Adeoye-Olatunde10

Shannon Risacher2,11 Andrew Saykin2,8,12,13 Sophia Wang2,14

Affiliations:

1University of Texas Health San Antonio, San Antonio, Texas, USA

2Indiana Alzheimer’s Disease Research Center, Indianapolis, Indiana, USA

3Indiana University School of Nursing Science of Nursing Care Department, Indianapolis, Indiana, USA

4VA HSR&D Center for Health Information and Communication, Roudebush VA Medical Center, Indianapolis, Indiana, USA

5Regenstrief Institute, Center for Health Services Research, Indianaplis, Indiana, USA

6Women’s Health Sciences Division, National Center for PTSD, VA Boston Healthcare System, Boston, Massachusetts, USA

7Department of Internal General Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA

8Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA

9Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA

10Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana, USA

11Department of Radiology and Imaging Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA

12Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA

13Indiana University Network Science Institute, Bloomington, Indiana, USA

14Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA

Partners

Related News

Kathleen Unroe, M.D.

NEXT STEPs conference at Regenstrief Institute educates audience about including nursing home residents in clinical trials

The NEXT STEPs Conference, held at Regenstrief Institute on September 9-10, 2025, brought together a diverse group of clinical

Regenstrief Research Scientist Wanzhu Tu, PhD

Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States

Published in the Journal of Hepatology. Here is a link to the article.  Regenstrief Institute author: Wanzhu Tu, PhD.

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals